In conclusion, in different type of stomach cancer cell lines, the expression of HER-2 protein is different, so different anti-cancer compounds (doxorubicin, cisplatin, paclitaxel and 5-FU) should be used depends on the expression of HER-2. The gene discussed is ERBB2; the disease is gastric neoplasm.